(Q40573557)

21 September 2017

title

CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients (English)

1 reference

21 September 2017

Lautenschlager I

1

1 reference

21 September 2017

Lappalainen M

2

1 reference

21 September 2017

Linnavuori K

3

1 reference

21 September 2017

Suni J

4

1 reference

21 September 2017

Höckerstedt K

5

1 reference

21 September 2017

language of work or name

1 reference

1 August 2002

1 reference

Journal of Clinical Virology

21 September 2017

published in

1 reference

21 September 2017

volume

25 Suppl 2

1 reference

21 September 2017

page(s)

S57-61

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

21 September 2017

1 reference

7 January 2021

Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus-6 and -7 in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesviruses 6 and 7 in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Longitudinal study of human herpesvirus 6 infection in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus-6 infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus-6 antigenemia after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus 6 (HHV-6).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human beta-herpesvirus interactions in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

"Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

CD46 is a cellular receptor for human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesviruses-6, -7 and -8 in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Human herpesvirus 7: another causal agent for roseola (exanthem subitum)

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900101-4

7 January 2021

10.1016/S1386-6532(02)00101-4

Identifiers

DOI

1 reference

21 September 2017

1 reference